Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Entegris Inc (ENTG) vs Global X Defense Tech ETF (SHLD) Price & Performance

Entegris IncTrade
Global X Defense Tech ETFTrade

Price performance (Past 24H)

Key statistics

Entegris Inc vs Global X Defense Tech ETF — how do they compare? Entegris Inc trades at $162.41 (market cap $24.78B), while Global X Defense Tech ETF trades at $59.16 (market cap $6.29B). The key difference: Entegris Inc is far larger — about 3.9× Global X Defense Tech ETF's market cap, and Entegris Inc pays a 0.25% dividend while Global X Defense Tech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Entegris Inc for 41 Days and Global X Defense Tech ETF for 44 Days on average.

ENTGSHLD
Market Cap
$24.78B$6.29B
Volume
2,648,3201,133,252
Sector
TechnologySector/Thematic
52-Week High
$184.00$78.02
52-Week Low
$68.80$58.20
Typical Hold Time
41 Days44 Days
Enterprise Value
$27.99B—
Dividend Yield
0.25%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Entegris Inc

ENTG trades at $166.32, down 0.34% on the day, with a bullish technical signal and strong institutional backing. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $0.93 surpassing the $0.822 forecast. Revenue remains stable around $3.2B, while profitability metrics show a net income margin of 9.18%. Recent news highlights robust AI-driven semiconductor demand and successful patent defenses.

The outlook is positive, supported by analyst consensus with a $182.43 price target and 70% buy ratings. Key opportunities include exposure to growing semiconductor complexity and AI investments. Risks involve high valuation multiples, such as a P/E of 81.1, and sensitivity to semiconductor industry cycles.

Global X Defense Tech ETF

SHLD, the Global X Defense Tech ETF, trades at $58.74, down 2.2% on the day amid a bearish technical signal. The ETF focuses on defense technology and cybersecurity, with recent institutional buying interest noted in filings. However, key financial ratios like P/E and P/S are not available for this ETF, and the overall technical picture is negative, with moving averages and oscillators signaling bearish momentum.

The outlook for SHLD is mixed, with potential tailwinds from rising global defense spending and institutional accumulation, but weighed down by bearish technicals and the absence of clear valuation metrics. Risks include geopolitical shifts and ETF-specific performance versus peers. The investment case hinges on sustained defense budget growth and SHLD's ability to capture tech-driven defense innovation.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ENTG
34% Buy66% Sell
Avg holding period · 41 Days
SHLD

No sentiment data available yet.

Top news

Latest headlines on both assets

About Entegris Inc

Entegris Inc is a supplier of advanced materials and process solutions for the semiconductor and other high-technology industries. The company's reportable segments include Specialty Chemicals & Engineered Materials (SCEM), Microcontamination Control (MC), and Advanced Materials Handling (AMH). The SCEM segment provides high-performance & high-purity process chemistries, gases, & materials, and safe & efficient delivery systems. The Microcontamination Control (MC) segment includes solutions to purify critical liquid chemistries and process gases used in semiconductor manufacturing processes and other high-technology industries. Its geographical segments are Taiwan, North America, South Korea, Japan, China, Europe, and Southeast Asia.

Read more on ENTG →

About Global X Defense Tech ETF

SHLD tracks the Global X Defense Tech Index, targeting companies that lead the technological transformation of the defense sector. It focuses on pure-play innovators in cybersecurity, artificial intelligence, robotics, and advanced military systems, excluding traditional commercial aerospace to maintain a high level of thematic purity.

Read more on SHLD →